Mamotest

Not verified. Claim this page

Sustainability Summary

  • This is an unclaimed profile. Mamotest has not joined Sustainability Tracker to verify their sustainability credentials. We gathered what we could from public sources.
Powered by Tracker AI BETA; there may be errors

Mamotest Sustainability Profile

Sustainability Summary

  • This is an unclaimed profile. Mamotest has not joined Sustainability Tracker to verify their sustainability credentials. We gathered what we could from public sources.
Powered by Tracker AI BETA; there may be errors

What do our labels mean?

Certified B Corporation Logo

Certified B Corporation

UNGC Participant Logo

UNGC Participant

Mamotest is an Argentina-based health-tech SME and Latin America’s first tele-mammography network. Its sustainability-related work is centred on improving access to breast cancer screening and treatment for women in underserved and underprivileged communities. The company uses AI-powered mammography services, works with existing labs to provide low-cost mammograms, and says its platform provides traceability of patients and continuous follow-up until treatment. After winning the Zayed Sustainability Prize in 2022, Mamotest expanded beyond Argentina to Mexico, Costa Rica, Brazil and Spain.

About Mamotest

  • Status
  • Unverified
  • Employees
  • 5 - 25
  • Country
  • Argentina

Mamotest Sustainability Actions

Deployed AI mammography in Costa Rica

Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, announced the deployment of AI-powered mammography services across Costa Rica. These services will support the early detection and treatment of breast cancer for women living in underprivileged communities. Eight thousand tests will be conducted annually using the AI-based mammography services, which have been deployed in Juan Pablo II Medical Centre in Cartago.

Reached underserved areas by mobile unit

A mobile unit, which is owned and operated by CENRAD, has also been deployed to reach underserved areas across Costa Rica where access to healthcare may be limited. The mobile unit has reached 840 women across 13 locations since January.

Expanded diagnostic centres regionally

After winning the Zayed Sustainability Prize in 2022, Mamotest expanded operations of its state-of-the-art diagnostic centres beyond Argentina to Mexico, Costa Rica, Brazil and Spain. Now, it works with existing labs to provide high-quality mammograms at low cost, enabling women to overcome geographical, technological, and economic barriers to access healthcare.

Provided patient traceability

Our platform ensures 100 percent traceability of patients and provides continuous follow-up until they receive treatment.

Provided low-cost healthcare

Mamotest is an Argentina-based health-tech SME and Latin America’s first tele-mammography network. It has provided low-cost healthcare to more than 750,000 patients and promoted awareness for millions in the region.

Mamotest Sustainability Commitments

2024

Deploy services in more facilities

There are also plans to deploy these services in additional health facilities in the future.


What do our labels mean?

Certified B Corporation Logo

Certified B Corporation

UNGC Participant Logo

UNGC Participant

About Mamotest

  • Status
  • Unverified
  • Employees
  • 5 - 25
  • Country
  • Argentina

Sustainable Development Goals

Mamotest is committed to advancing these Global Goals to promote prosperity for people & planet.

 Logo

 Logo

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.